← Back to Search

Behavioural Intervention

MCII + MOVE! Program for Weight Management (WOOP VA Trial)

New York, NY
N/A
Waitlist Available
Led By Melanie R. Jay, MD MS
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
BMI of 30kg/m2 (with or without obesity-associated comorbidities) OR a BMI of 25kg/m2 with obesity-associated condition (heart diseases, hyperlipidemia, hypertension, cancer, diabetes, stroke, or osteoarthritis)
Age 18-70
Must not have
a documented current history of active psychosis or other cognitive issues via ICD-10 codes
Diagnosed with Parkinson's disease and/or severe arthritis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test whether adding a mental contrasting with implementation intentions (MCII) strategy to the VA's MOVE! weight management program will help Veterans who are enrolled in the program to lose weight.

See full description
Who is the study for?
This trial is for Veterans aged 18-70 with obesity or related conditions, willing to join the MOVE! program and able to attend evaluations in Manhattan VA. They must have had a primary care visit within the past year, desire weight loss, and be reachable by phone. Excluded are those seeing dietitians frequently, recently hospitalized, involved in other weight studies or taking certain weight loss drugs.Check my eligibility
What is being tested?
The study tests whether adding Mental Contrasting with Implementation Intentions (MCII) strategy via 'WOOP' technique to telephone-delivered MOVE! enhances weight management compared to just using telephone-delivered MOVE!. Participants will receive guidance on diet and exercise during baseline visits and follow-up check-ins.See study design
What are the potential side effects?
Since this trial involves lifestyle interventions like dietary changes and physical activity rather than medication, side effects may include typical exercise-related issues such as muscle soreness or fatigue. Psychological discomfort could also occur from changing long-standing habits.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My BMI is 30 or higher, or it's 25 or higher with a related health condition.
 show original
Select...
I am between 18 and 70 years old.
 show original

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with active psychosis or cognitive issues.
 show original
Select...
I have been diagnosed with Parkinson's disease or severe arthritis.
 show original

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in Self Reported Physical Activity
Healthy Eating Index change
MOVE! Attendance change
+3 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mental Contrasting with Implementation Intentions (WOOP) plus MOVE! /TeleMOVE!Experimental Treatment4 Interventions
At the baseline visit, a lay educator will teach the WOOP technique in-person using protocols adapted from our prior work. After, to support WOOP practice, the lay educator will schedule and provide 3 follow-up telephone check-ins with the Veteran. This arm will also receive telephone-delivered MOVE!/TeleMOVE!
Group II: Telephone Delivered MOVE!/TeleMOVE!Active Control2 Interventions
During the baseline visit, Veterans randomized to the control arm will receive only the standard information about MOVE!/TeleMOVE!, diet, and physical activity delivered by the same lay educators. They will not learn the WOOP technique as detailed below. Data collection during study visits will be at the same timepoints in both arms.

Find a Location

Closest Location:VA NY Harbor Healthcare System, New York, NY· New York, NY

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,687 Previous Clinical Trials
3,758,341 Total Patients Enrolled
43 Trials studying Obesity
15,956 Patients Enrolled for Obesity
New York UniversityOTHER
247 Previous Clinical Trials
228,323 Total Patients Enrolled
7 Trials studying Obesity
3,712 Patients Enrolled for Obesity
Melanie R. Jay, MD MSPrincipal InvestigatorVA NY Harbor Healthcare System, New York, NY
2 Previous Clinical Trials
346 Total Patients Enrolled
2 Trials studying Obesity
346 Patients Enrolled for Obesity

Media Library

telephone-delivered MOVE! (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05014984 — N/A
Obesity Research Study Groups: Telephone Delivered MOVE!/TeleMOVE!, Mental Contrasting with Implementation Intentions (WOOP) plus MOVE! /TeleMOVE!
Obesity Clinical Trial 2023: telephone-delivered MOVE! Highlights & Side Effects. Trial Name: NCT05014984 — N/A
telephone-delivered MOVE! (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05014984 — N/A
~30 spots leftby Jun 2025